Document is current

Any future updates will be listed below

The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas

Crossref DOI link: https://doi.org/10.1007/s00520-017-3696-6

Published Online: 2017-04-11

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark